{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:58:01Z","timestamp":1774342681802,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Angiopoietin-like protein 8 (ANGPTL8), a secreted adipokine, has been reported to be associated with lipid and glucose metabolism. This study aimed to evaluate the association between circulating levels of ANGPTL8 and atherogenic risk, assessed by the atherogenic index of plasma (AIP), in diabetic individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 228 patients with type 2 diabetes (T2D) were included in this cross-sectional study. The AIP was calculated as the logarithm of the ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-c) and divided into two subgroups of low and high risk of CVD, as &amp;lt;0.11 and \u22650.11, respectively. Data including clinical characteristics and laboratory tests were collected. Serum levels of ANGPTL8 were assessed by ELISA analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serum concentrations of ANGPTL8 were significantly higher in the high AIP group compared with the low AIP group [293.84 (255.63\u2013332.05) ng\/mL vs. 223.05 (202.85\u2013243.25) ng\/mL;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001]. Serum ANGPTL8 levels were positively correlated with AIP values in patients with T2D as shown by Spearman correlation analysis (r\u2009=\u20090.133,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). After adjusting for confounding factors, elevated ANGPTL8 levels remained significantly associated with high AIP (OR, 0.010; 95% CI: 0.994\u20130.999;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.010). The optimal cutoff value of ANGPTL8 for identifying high AIP was 227.18\u2005ng\/mL (sensitivity\u2009=\u200968.40%; specificity\u2009=\u200968.00%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001; AUC\u2009=\u20090.780; 95% CI: 0.714\u20130.847).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:\u2005<\/jats:title>\n                    <jats:p>The serum ANGPTL8 levels are elevated in T2D patients with high AIP. Increased ANGPTL8 levels are closely associated with higher AIP values, indicating a predictive value of ANGPTL8 in atherosclerosis in patients with T2D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1762073","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:25:23Z","timestamp":1774329923000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between serum ANGPLT8 levels and atherogenic index of plasma in Chinese patients with type 2 diabetes mellitus"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoya","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Beijing Tongren Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","article-title":"Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels","volume":"424","author":"Zhang","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1742-4658.2010.07979.x","article-title":"Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases","volume":"278","author":"Kadomatsu","year":"2011","journal-title":"FEBS J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"19751","DOI":"10.1073\/pnas.1217552109","article-title":"Atypical angiopoietin-like protein that regulates ANGPTL3","volume":"109","author":"Quagliarini","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.molmet.2017.06.014","article-title":"ANGPTL8 Promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase","volume":"6","author":"Chi","year":"2017","journal-title":"Mol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1194\/jlr.M075689","article-title":"ANGPTL8 Requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance","volume":"58","author":"Haller","year":"2017","journal-title":"J Lipid Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.diabres.2016.08.017","article-title":"Increased angiopoietin-like protein 8 levels in patients with type 2 diabetes and cardiovascular disease","volume":"120","author":"Huang","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1507\/endocrj.EJ19-0263","article-title":"Regulation of angiopoietin-like protein 8 expression under different nutritional and metabolic status","volume":"66","author":"Guo","year":"2019","journal-title":"Endocr J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"10949","DOI":"10.1038\/srep10949","article-title":"Higher plasma betatrophin\/ANGPTL8 level in type 2 diabetes subjects does not correlate with blood glucose or insulin resistance","volume":"5","author":"Abu-Farha","year":"2015","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"323407","DOI":"10.1155\/2014\/323407","article-title":"Increased circulating betatrophin concentrations in patients with type 2 diabetes","volume":"2014","author":"Espes","year":"2014","journal-title":"Int J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8293207","DOI":"10.1155\/2017\/8293207","article-title":"Increased serum ANGPTL8 concentrations in patients with prediabetes and type 2 diabetes","volume":"2017","author":"Yin","year":"2017","journal-title":"J Diabetes Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12933-018-0687-y","article-title":"Triglyceride-mediated infuence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China","volume":"17","author":"Zheng","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12974-024-03183-8","article-title":"Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathway","volume":"21","author":"Meng","year":"2014","journal-title":"J Neuroinflammation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"695750","DOI":"10.3389\/fendo.2021.695750","article-title":"Association of ANGPTL8 and resistin with diabetic nephropathy in type 2 diabetes Mellitus","volume":"12","author":"Li","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","first-page":"248","article-title":"Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in enugu, Nigeria","volume":"10","author":"Nwagha","year":"2010","journal-title":"Afr Health Sci"},{"key":"B15","first-page":"64","article-title":"AIP\u2013Atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice","volume":"52","author":"Dobi\u00e1sov\u00e1","year":"2006","journal-title":"Vnitr Lek"},{"key":"B16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12944-017-0545-z","article-title":"Fractional esterification rate of cholesterol in high-density lipoprotein associates with risk of coronary heart disease","volume":"16","author":"Liu","year":"2017","journal-title":"Lipids Health Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1515\/cclm-2013-0525","article-title":"A simple and precise method for direct measurement of fractional esterification rate of high density lipoprotein cholesterol by high performance liquid chromatography","volume":"52","author":"Dong","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"B18","first-page":"152","article-title":"The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy","volume":"46","author":"Dobi\u00e1sov\u00e1","year":"2000","journal-title":"Vnitr Lek"},{"key":"B19","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12944-018-0828-z","article-title":"Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women","volume":"17","author":"Wu","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2014.09.028","article-title":"Perspectives on the activities of ANGPTL8\/betatrophin","volume":"159","author":"Yi","year":"2014","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"E2004","DOI":"10.1210\/jc.2014-1568","article-title":"Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes","volume":"99","author":"Gomez-Ambrosi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/oby.21038","article-title":"Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals","volume":"23","author":"Guo","year":"2015","journal-title":"Obesity"},{"key":"B24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00592-021-01801-y","article-title":"The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older Chinese","volume":"59","author":"Yi","year":"2022","journal-title":"Acta Diabetol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pcd.2014.03.007","article-title":"Meta-analysis of atherogenic index of plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus","volume":"9","author":"Zhu","year":"2015","journal-title":"Prim Care Diabetes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/1753-0407.12836","article-title":"Dose-response association between the triglycerides: high-density lipoprotein cholesterol ratio and type 2 diabetes mellitus risk: the rural Chinese cohort study and meta-analysis","volume":"11","author":"Cheng","year":"2019","journal-title":"J Diabetes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12933-024-02341-9","article-title":"Association between atherogenic index of plasma and gestational diabetes mellitus: a prospective cohort study based on the Korean population","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1476-511X-9-85","article-title":"Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women","volume":"9","author":"Hadaegh","year":"2010","journal-title":"Lipids Health Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11010-020-03725-7","article-title":"Higher circulating levels of ANGPTL8 are associated with body mass index, triglycerides, and endothelial dysfunction in patients with coronary artery disease","volume":"469","author":"Fadaei","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1038\/s41467-017-02355-w","article-title":"ANGPTL8 Negatively regulates NF-\u03baB activation by facilitating selective autophagic degradation of IKK\u03b3","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12933-016-0346-0","article-title":"Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome","volume":"15","author":"Abu-Farha","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.5551\/jat.46508","article-title":"Associations between plasma betatrophin levels and coronary and peripheral artery disease","volume":"26","author":"Niki","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"Visser","year":"1999","journal-title":"JAMA"},{"key":"B36","doi-asserted-by":"publisher","first-page":"107255","DOI":"10.1016\/j.vph.2023.107255","article-title":"Inflammation and the pathogenesis of atherosclerosis","volume":"154","author":"Libby","year":"2014","journal-title":"Vascul Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.medcli.2020.04.024","article-title":"Atherosclerosis\u2002and\u2002inflammation. New therapeutic approaches","volume":"155","author":"Pedro-Botet","year":"2020","journal-title":"Med Clin (Barc)"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1762073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:25:24Z","timestamp":1774329924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1762073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":37,"alternative-id":["10.3389\/fcvm.2026.1762073"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1762073","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"article-number":"1762073"}}